Atrial fibrillation in breast cancer therapy: does tamoxifen confer a lower risk than aromatase inhibitors?
Cardiooncology. 2025 May 31;11(1):51. doi: 10.1186/s40959-025-00352-3.ABSTRACTINTRODUCTION: Aromatase inhibitors (AIs) have been linked to increased atrial fibrillation(AF) risk due to estrogen depletion however tamoxifen's effect on AF remains conflicting. This study investigates the risk of AF ass